Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism four-year follow-up and comparison with healthy postmenopausal women

Archives of Internal Medicine

Volumn 160, Issue 14, 2000, Pages 2161-2166

  Orr Walker, Brandon J ^a   Evans, Margaret C ^a   Clearwater, Judy M ^a   Horne, Anne ^a   Grey, Andrew B ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; LONG TERM CARE; OSTEOPENIA; PARATHYROIDECTOMY; POSTMENOPAUSE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034710294     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.14.2161     Document Type: Article

References (30)

1. Palmer M, Jakobsson S, Akerstrom G, Ljunghall S. Prevalence of hypercalcaemia in a health survey: a 14-year follow-up study of serum calcium values. Eur J Clin Invest. 1988;18:39-46.
2. Melton LJ. Epidemiology of primary hyperparathyroidism. J Bone Miner Res. 1991; 6(suppl 2):S25-S29.
3. Paterson CR, Burns J, Mowat E. Long term follow up of untreated primary hyperparathyroidism. BMJ. 1984;289:1261-1263.
4. Parfitt AM, Rao DS, Kleerekoper M. Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. J Bone Miner Res. 1991; 6(suppl 2):S97-S101.
5. Rubinoff H, McCarthy N, Hiatt RA. Hypercalcemia: long-term follow-up with matched controls. J Chronic Dis. 1983;36:859-868.
6. Grey AB. The skeletal effects of primary hyperparathyroidism. Baillieres Clin Endocrinol Metab. 1997;11:101-116.
7. Elvius M, Lagrelius A, Nygren A, Alveryd A, Christensson TAT, Nordenstrom J. Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism, some of whom were operated on. Eur J Surg. 1995; 161:863-869.
8. Diamond T, Ng ATM, Levy S, Magarey C, Smart R. Estrogen replacement may be an alternative to parathyroid surgery for the treatment of osteoporosis in elderly postmenopausal women presenting with primary hyperparathyroidism: a preliminary report. Osteoporos Int. 1996;6:329-333.
9. Guo CY, Thomas WEG, Aldehaimi AW, Assiri AMA, Eastell R. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81: 3487-3491.
10. Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR. Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism: a randomized, controlled trial. Ann Intern Med. 1996; 125:360-368.
11. Grey AS, Evans MC, Stapleton JP, Reid IR. Body weight and bone mineral density in postmenopausal women with primary hyperparathyroidism. Ann Intern Med. 1994;121:745-749.
12. Garton M, Martin J, Stewart A, et al. Changes in bone mass and metabolism after surgery for primary hyperparathyroidism. Clin Endocrinol. 1995;42:493-500.
13. Silverberg SJ, Gartenberg F, Jacobs TP, et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab. 1995;80:729-734.
14. Abugassa S, Nordenstrom J, Eriksson S, Mollerstrom G, Alveryd A. Skeletal remineralization after surgery for primary and secondary hyperparathyroidism. Surgery. 1990;107:128-133.
15. Clyde JW, Wittert GA, Gilchrist NL, Tarner JG, Donald RA, Espiner EA. The effect of parathyroidectomy on bone mineral density in primary hyperparathyroidism. N Z Med J. 1992;105:71-72.
16. Warner J, Clifton-Bligh P, Posen S, McElduff A, Delbridge L, Reeve T. Longitudinal changes in forearm bone mineral content in primary hyperparathyroidism. J Bone Miner Res. 1991;6(suppl 2):91-95.
17. Silverberg SJ, Shane E, de la Cruz L, et al. Skeletal disease in primary hyperparathyroidism. J Bone Miner Res. 1989;4:283-291.
18. Parisien M, Cosman F, Mellish RWE, et al. Bone structure in postmenopausal hyperparathyroid, osteoporotic, and normal women. J Bone Miner Res. 1995; 10:1393-1399.
19. Eriksen EF, Mosekilde L, Melsen F. Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone. 1986;7:213-221.
20. Grey AB, Stapleton JP, Evans MC, Reid IR. Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism. Clin Endocrinol. 1996; 44:697-702.
21. Silverberg SJ, Gartenberg F, Jacobs TP, et al. Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab. 1995;80:723-728.
22. Ljunghall S, Palmer M, Akerstrom G, Wide L. Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy. Eur J Clin Invest. 1983;13:373-377.
23. Hesp R, Tellez M, Davidson L, Elton A, Reeve J. Trabecular and cortical bone in the radii of women with parathyroid adenomata: a greater trabecular deficit, with a preliminary assessment of recovery after parathyroidectomy. Bone Miner. 1987; 2:301-310.
24. McDermott MT, Perlotf JJ, Kidd GS. Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy. J Bone Miner Res. 1994;9:509-514.
25. Melton LJ, Atkinson EJ, O'Fallon WM, Heath H. Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med. 1992;152:2269-2273.
26. Khosla S, Melton LJ, Wermers RA, Crowson CS, O'Fallon WM, Riggs BL. Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res. 1999;14:1700-1707.
27. Larsson K, Ljunghall S, Krusemo UB, Naessen T, Lindh E, Persson I. The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. J Intern Med. 1993;234:585-593.
28. Grey A, Reid I. Body weight and bone mineral density in hyperparathyroidism [letter]. Ann Intern Med. 1995;123:732.
29. Landin-Wilhelmsen K, Lappas G, Rosen T, et al. Serum intact parathyroid hormone in a random population sample of men and women: relationship to anthropometry, life-style factors, blood pressure, and vitamin D. Calcif Tissue Int. 1995;56:104-108.
30. Wareham NJ, Byrne CD, Carr C, Day NE, Boucher BJ, Hales CN, Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism. 1997;46:1171-1177.